XML 77 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) (USD $)
In Thousands, except Share data
Total
Class A Common Stock
Class B Common Stock
Series A preferred stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning Balance at Feb. 28, 2011 $ (141,985) $ 335 $ 47   $ 528,786 $ (720,693) $ 1,776 $ 47,764
Beginning Balance (in shares) at Feb. 28, 2011   33,499,770 4,722,684          
Net income 30,728         26,193   4,535
Exercise of stock options and related income tax benefits (In shares)   10,000            
Exercise of stock options and related income tax benefits 3       3      
Issuance of Common Stock to employees and officers and related income tax benefits (In shares)   497,509            
Issuance of Common Stock to employees and officers and related income tax benefits 1,009 5     1,004      
Payments of dividends and distributions to noncontrolling interests (246)             (246)
Payments of dividends and distributions to noncontrolling interests (4,152)             (4,152)
Preferred stock transactions 61,892         61,892    
Cumulative translation adjustment (156)           (97) (59)
Change in value of derivative instrument (489)           (489)  
Ending Balance at Feb. 29, 2012 (53,396) 340 47   529,793 (632,608) 1,190 47,842
Ending Balance (in shares) at Feb. 29, 2012   34,007,279 4,722,684          
Net income 48,251         43,772   4,479
Exercise of stock options and related income tax benefits (In shares)   784,376            
Exercise of stock options and related income tax benefits 302 8     294      
Issuance of Common Stock to employees and officers and related income tax benefits (In shares)   605,205            
Issuance of Common Stock to employees and officers and related income tax benefits 1,601 6     1,595      
Issuance of Common Stock in exchange for cancellation of stock options (In shares)   511,065            
Issuance of Common Stock in exchange for cancellation of stock options   5            
Acquisition of additional controlling interests 5              
Payments of dividends and distributions to noncontrolling interests (5,103)             (5,103)
Reclassify preferred stock from mezzanine (In shares)       937,641        
Reclassify preferred stock from mezzanine 46,882     9 46,873      
Cumulative translation adjustment (1,249)           (1,201) (48)
Change in value of derivative instrument (107)           (107)  
Ending Balance at Feb. 28, 2013 37,099 359 47 9 578,555 (588,836) (118) 47,083
Ending Balance (in shares) at Feb. 28, 2013   35,907,925 4,722,684 937,641        
Net income 48,655         43,481   5,174
Exercise of stock options and related income tax benefits (In shares) 434,500 [1] 425,800            
Exercise of stock options and related income tax benefits 329 4     325      
Issuance of Common Stock to employees and officers and related income tax benefits (In shares)   780,178            
Issuance of Common Stock to employees and officers and related income tax benefits 2,012 9     2,003      
Conversion of Class B Common Stock to Class A Common Stock (in shares)   153,220 (153,220)          
Conversion of Class B Common Stock to Class A Common Stock   1 (1)          
Purchase of preferred stock (in shares)       (8,650)        
Purchase of preferred stock (107)       (107)      
Payments of dividends and distributions to noncontrolling interests (4,620)             (4,620)
Cumulative translation adjustment (8)           11 (19)
Change in value of derivative instrument 8           8  
Ending Balance at Feb. 28, 2014 $ 83,368 $ 373 $ 46 $ 9 $ 580,776 $ (545,355) $ (99) $ 47,618
Ending Balance (in shares) at Feb. 28, 2014   37,267,123 4,569,464 928,991        
[1] The Company did not record an income tax benefit related to option exercises in the year ended February 28 (29), 2012, 2013 and 2014. Cash received from option exercises during the years ended February 2012, 2013 and 2014 was less than $0.1 million, $0.3 million and $0.3 million, respectively.